交易中
0.000
NaN.00%
Agreement paves the way for newly diagnosed, transplant-ineligible patients fighting multiple myeloma to access first-line treatment Sarclisa® through provincial and territorial cancer treatment formulary listings.
11-16 22:16
炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! (来源:凤凰WEEKLY财经) 11月5日至10日,第九届中国国际进口博览会在上...
11-10 16:31
10月20-22日上海黄浦江畔,2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势,更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-16 22:46
Regeneron reports positive trial data for ubamatamab in ovarian cancer and trevogrumab for muscle preservation during weight loss.
10-03 01:19
Sanofi discontinued amlitelimab for atopic dermatitis after reviewing phase 3 efficacy and safety data, ending plans for regulatory filings.
07-25 02:10
The US Food and Drug Administration (FDA) has approved subcutaneous (SC) Sarclisa (isatuximab-irfc) Escena in combination with standard-of-care regimens for the treatment of patients with multiple myeloma (MM) across
07-10 20:55
ARS Pharma (SPRY) co-founder Richard Lowenthal steps down as CEO. President Donn Casale succeeds him amid a strategic shift.
07-10 01:37
Sino Biopharma expanded its GSK partnership in China and signed an AstraZeneca licensing deal worth up to $2.1 billion.
07-08 22:14
文|智讯智库分析师 李伯睿 AI 制药已经开始走进药企巨头的日常工作流。 强生(NYSE: JNJ)率先交出一份颇有说服力的成绩单:先导化合物优化时间直接砍半...
07-01 15:04
EU opens antitrust probe into Sanofi over claims it disparaged rival flu vaccine Fluad in Germany and France.
06-29 23:44